Inhibition of growth of cervical cancer cells using a dominant negative estrogen receptor gene

被引:21
作者
Au, William W. [1 ]
Abdou-Salama, Salama
Al-Hendy, Ayman
机构
[1] Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA
[2] Univ Texas, Med Branch, Dept Obstet & Gynecol, Galveston, TX 77550 USA
关键词
cervical cancer; estrogen receptor; estrogen; molecular intervention; gene therapy; cyclin D1; HPV; dominant negative estrogen receptor gene;
D O I
10.1016/j.ygyno.2006.10.015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. Estrogen stimulates human papilloma virus oncogene expression, promotes cervical cancer (CC) cell proliferation and prevents apoptosis. Therefore, blockage of estrogen function may have therapeutic application to CC. Methods. CasKi CC cells were transfected with an adenovirus expressing a dominant negative estrogen receptor gene (Ad-ER-DN) and their responses were investigated by RT-PCR, Flow Cytometry and Western blot assays. Result. Transfected cells showed disturbance of cell colony morphology, reduced HPV E6 and E7 mRNA, interruption of cell proliferation, reduced cyclin D1 protein and expression of apoptosis. Conclusion. We report, for the first time, the use of Ad-ER-DN to block estrogen receptors which led to dramatic changes in CC cells that are consistent with the possible reactivation of cellular p53 and Rb function. Their reactivation most likely allowed the recognition of existing chromosome abnormalities as a serious stress signal and the initiation of a cascade of cellular events in response to the stress, including the activation of the core apoptotic machinery which led to self-destruction of the CC cells. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:276 / 280
页数:5
相关论文
共 29 条
[1]   Cyclin D1 is essential for neoplastic transformation induced by both E6/E7 and E6/E7/ErbB-2 cooperation in normal cells [J].
Al Moustafa, AE ;
Foulkes, WD ;
Wong, A ;
Jallal, H ;
Batist, G ;
Yu, QY ;
Herlyn, M ;
Sicinski, P ;
Alaoui-Jamali, MA .
ONCOGENE, 2004, 23 (30) :5252-5256
[2]   Gene therapy of uterine leiomyomas: Adenovirus-mediated expression of dominant negative estrogen receptor inhibits tumor growth in nude mice [J].
Al-Hendy, A ;
Lee, EJ ;
Wang, HQ ;
Copland, JA .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2004, 191 (05) :1621-1631
[3]   Ovarian cancer gene therapy: Repeated treatment with thymidine kinase in an adenovirus vector and ganciclovir improves survival in a novel immunocompetent murine model [J].
Al-Hendy, A ;
Magliocco, AM ;
Al-Tweigeri, T ;
Braileanu, G ;
Crellin, N ;
Li, H ;
Strong, T ;
Curiel, D ;
Chedrese, PJ .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (03) :553-559
[4]   Human papillomavirus infection and cyclin D1 gene amplification in laryngeal squamous cell carcinoma: Biologic function and clinical significance [J].
Almadori, G ;
Galli, J ;
Cadoni, G ;
Bussu, F ;
Maurizi, M .
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2002, 24 (06) :597-604
[5]  
ARK JS, 2003, GYNAECOL ONCOL, V89, P360
[6]  
AU WW, IN PRESS INT J HYGIE
[7]   Estrogen contributes to the onset, persistence, and malignant progression of cervical cancer in a human papillomavirus-transgenic mouse model [J].
Brake, T ;
Lambert, PF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (07) :2490-2495
[8]  
Chen DZ, 2004, ANTICANCER RES, V24, P2649
[9]   A fusion protein of the estrogen receptor (ER) and nuclear receptor corepressor (NCoR) strongly inhibits estrogen-dependent responses in breast cancer cells [J].
Chien, PY ;
Ito, M ;
Park, Y ;
Tagami, T ;
Gehm, BD ;
Jameson, JL .
MOLECULAR ENDOCRINOLOGY, 1999, 13 (12) :2122-2136
[10]  
Curiel DT, 2000, BREAST CANCER RES, V2, P45